Exploitation, go-to-market & industry partner for Cluster 1 Health 2027 consortia

AxioTechBio is looking to join consortia preparing proposals under the Horizon Europe Cluster 1 Health 2027 calls (stage 1 / single-stage deadline 17 February 2027), in particular topics with strong exploitation and market uptake requirements, such as IND-02 (point-of-care diagnostics), TOOL-01 (AI predictive biomarkers), CARE-02, DISEASE-01, DISEASE-14 and IND-01. We are also open to other topics where our profile adds value.

What we offer:

– Contribution to exploitation and industry uptake work packages

– Market and end-user needs analysis, value proposition and business models

– Market & Procurement Readiness Kit: exploitable results map, FR/ES market sizing, public procurement map (buyers, procedures, tender calendars, award criteria), go-to-market and sustainability plan

– Industry-facing communication and dissemination

– Support to consortium building

– Industry bridge: access to a broad and growing network of European SMEs in omics, molecular diagnostics, bioinformatics, medical devices and digital health

We are open to all partner types that fit the project:

– Coordinators (academic, clinical, research organisations or companies) looking for an exploitation partner

– SMEs from across Europe with diagnostic, biomarker, medtech, AI or digital health technologies seeking a consortium or a partner to strengthen their exploitation strategy

– Clinical centres, patient organisations and other end users in France and Spain

– Partners with regulatory (IVDR/MDR) and HTA expertise, to build complementary exploitation teams

Why AxioTechBio:

– We execute, not only plan: nearly 20 years selling genomics and diagnostics to hospitals and research centres

– Hands-on public procurement experience in France and Spain

– Post-project route to market: we can commercially represent the exploitable results in France and Spain

– We bring industry: a network of European omics and diagnostics SMEs

Based in Paris, Barcelona and Copenhagen, AxioTechBio bridges academia, healthcare systems and industry to help project results reach the market.